Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015
Summary
GlobalDatas clinical trial report, Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Global Clinical Trials Review, H1, 2015 provides data on the Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 5
Introduction 6
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) 20
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Reata Pharmaceuticals, Inc. 27
Clinical Trial Overview of Reata Pharmaceuticals, Inc. 27
SkyePharma PLC 28
Clinical Trial Overview of SkyePharma PLC 28
Mundipharma International Limited 29
Clinical Trial Overview of Mundipharma International Limited 29
Clinical Trial Overview of Top Institutes / Government 30
University of Texas M. D. Anderson Cancer Center 30
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 30
Memorial Sloan Kettering Cancer Center 31
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 31
National Cancer Institute 32
Clinical Trial Overview of National Cancer Institute 32
Duke University 33
Clinical Trial Overview of Duke University 33
Northwestern University 34
Clinical Trial Overview of Northwestern University 34
Baylor College of Medicine 35
Clinical Trial Overview of Baylor College of Medicine 35
University Hospital, Bonn 36
Clinical Trial Overview of University Hospital, Bonn 36
National Cancer Center 37
Clinical Trial Overview of National Cancer Center 37
National Taiwan University Hospital 38
Clinical Trial Overview of National Taiwan University Hospital 38
University of Washington 39
Clinical Trial Overview of University of Washington 39
Five Key Clinical Profiles 40
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69
List Of Tables
List of Tables
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 20
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Reata Pharmaceuticals, Inc., 2015* 27
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by SkyePharma PLC, 2015* 28
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2015* 29
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 30
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 31
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 32
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 33
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 34
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 35
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bonn, 2015* 36
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015* 37
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 38
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 39
List Of Figures
List of Figures
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 67
